Nuevocor, a clinical-stage biotechnology company pioneering mechanobiology-targeted therapies designed to address the root causes ...

The FDA-aligned pivotal efficacy population includes 12 male patients receiving commercial-grade RP-A501 at the recalibrated dose. The first three patients treated under the modified protocol count ...

Session: Advances in Oncology Panel Presenter: Walter Klemp, Chairman and Chief Executive Officer of Moleculin Date/time: Wednesday, October 14, 2026, from 9:00 - 10:00 a.m. ET Location: NYY Room at ...

Tishman Speyer secured $75 million from a German pension investor for its Korea living fund, lifting total equity commitments ...

Every year, numerous biotechnology innovations demonstrate promising results in the laboratory. Yet many of them never ...

State governments are grappling with how to regulate the emissions from plastics pyrolysis plants.

Danish biotech firm Genmab and US drugmaker AbbVie said on Monday their combination treatment for patients newly ​diagnosed ...

Vaxcyte Inc. stocks have been trading up by 56.14 percent, driven mainly by strong vaccine pipeline progress and investor ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and ...

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the formation of a Scientific Advisory Board (SAB) comprising seven accomplished scientific and industry leaders with deep expertise ...

The FDA has approved a surgically implanted pulmonary heart valve for pediatric patients with congenital pulmonary valve disease.  | The FDA has approved a surgically implanted pulmonary heart valve ...